Journal article
Bismuth-Based Quadruple Therapy Using a Single Capsule of Bismuth Biskalcitrate, Metronidazole, and Tetracycline Given With Omeprazole Versus Omeprazole, Amoxicillin, and Clarithromycin for Eradication of Helicobacter pylori in Duodenal Ulcer Patients: A Prospective, Randomized, Multicenter, North American Trial
Abstract
OBJECTIVES: This multicenter, randomized, active-controlled trial assessed efficacy of bismuth-based quadruple therapy with omeprazole, bismuth biskalcitrate, metronidazole, and tetracycline (OBMT) using a single-triple capsule of BMT compared with triple therapy with omeprazole, amoxicillin, and clarithromycin (OAC) in treatment of patients with Helicobacter pylori infection and duodenal ulcers.
METHODS: Patients with active duodenal ulcer or …
Authors
Laine L; Hunt R; El-Zimaity H; Nguyen B; Osato M; Spénard J
Journal
The American Journal of Gastroenterology, Vol. 98, No. 3,
Publisher
Wolters Kluwer
Publication Date
3 2003
DOI
10.1111/j.1572-0241.2003.t01-1-07288.x
ISSN
0002-9270
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
Administration, OralAdultAgedAmoxicillinAnti-Bacterial AgentsAnti-Ulcer AgentsCapsulesDrug Administration ScheduleDrug CombinationsDrug Therapy, CombinationDuodenal UlcerFemaleHelicobacter InfectionsHelicobacter pyloriHumansMaleMetronidazoleMiddle AgedNorth AmericaOmeprazoleOrganometallic CompoundsTetracyclineTreatment Outcome